The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders
Open accessAbstract
A growing body of researches support a role for dysfunction of serotoninergic, noradrenergic, and dopaminergic systems in the neurobiological processes involved in major depression disorder (MDD) and anxiety disorders (ADs). The physiological changes underlying abnormal signaling of 5-HT, NE, and DA may be due to either reduced presynaptic release of these neurotransmitters or aberrant signal transductions, and thus contributing to the alterations in regulation or function of receptors and/or impaired intracellular signal processing. Animal models demonstrate crucial responsiveness to disturbance of 5-HT, NE, and DA neurotransmissions. Postmortem and biochemical studies have shown altered concentrations of 5-HT, NE, and DA metabolites in brain regions that contribute importantly to regulation of mood and motivation in patients with MDD or ADs. Neuroimaging studies have found abnormal 5-HT, NE, and DA receptors binding and regulation in regard to receptor numbers. Medications that act on 5-HT, NE, and DA neurons or receptors, such as SSRIs and SNRIs, show efficacy in both MDD and ADs. The overlapping treatment response presumably suggests a common mechanism underlying the interaction of these disorders. In this paper, we reviewed studies from multiple disciplines to interpret the role of altered 5-HT, NE and DA mono-amine neurotransmitter functions in both MDD and ADs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,003
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Shin, L. M., & Liberzon, I. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.83 · Cited by 2,083 · cited 2×
“Studies have demonstrated reduced dopamine transporters density and D2 receptor binding in the striatum in patients with social anxiety disorder compared with healthy controls (Schneier et al., 2000; Shin and Liberzon, 2010).”
Background5-HIAA in the Cerebrospinal Fluid: A Biochemical Suicide Predictor?
Åsberg, M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770100055005 · Cited by 1,445
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · cited 4×
“Taken together, these findings support that 5-HT systems are a biochemical basis for MDD. Coppen and associates found that lack of 5-HT in the brain may cause depressive symptoms, including depressive mood, selfaccusation, and criticism (Coppen, 1967; Hogenelst et al., 2016).”
BackgroundInfluentialDopamine neurons modulate neural encoding and expression of depression-related behaviour
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073
Cingulate function in depression: a potential predictor of treatment response
Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L., Silva, J. A., McGinnis, S., Glass, T. G., Martin, C. C., et al. (1997) · NeuroReport · doi:10.1097/00001756-199703030-00048 · Cited by 1,029
Role of 5-HT in stress, anxiety, and depression
Graeff, F. G., Guimarães, F. S., De Andrade, T. G. C. S., & Deakin, J. F. W. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02135-3 · Cited by 984
Lemonde, S., Turecki, G., Bakish, D., Du, L., Hrdina, P. D., Bown, C. D., Sequeira, A., Kushwaha, N., Morris, S. J., Basak, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08788.2003 · Cited by 734
(2000) · PubMed · Cited by 685
Monoamine neurocircuitry in depression and strategies for new treatments
Hamon, M., & Blier, P. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.009 · Cited by 594
Castrén, E. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1629 · Cited by 563
Behavioral activation and inhibition systems and the severity and course of depression.
Kasch, K. L., Rottenberg, J., Arnow, B. A., & Gotlib, I. H. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.4.589 · Cited by 551
Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537
Charney, D. S., Woods, S. W., Goodman, W. K., & Heninger, G. R. (1987) · Psychopharmacology · doi:10.1007/bf00215473 · Cited by 462
Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression
Klimek, V., Stockmeier, C., Overholser, J., Meltzer, H. Y., Kalka, S., Dilley, G., & Ordway, G. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08451.1997 · Cited by 445
BLIER, P., de MONTIGNY, C., & CHAPUT, Y. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00003 · Cited by 404
Steffens, D. C., & Krishnan, K. R. R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00084-5 · Cited by 393
Goldberg, J. F., Burdick, K. E., & Endick, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.564 · Cited by 372
Reduced Serotonin Type 1AReceptor Binding in Panic Disorder: Figure 1.
Neumeister, A., Bain, E., Nugent, A. C., Carson, R. E., Bonne, O., Luckenbaugh, D. A., Eckelman, W., Herscovitch, P., Charney, D. S., & Drevets, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4921-03.2004 · Cited by 355
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study
Zarate, C. A., Payne, J. L., Singh, J., Quiroz, J. A., Luckenbaugh, D. A., Denicoff, K. D., Charney, D. S., & Manji, H. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.013 · Cited by 347
Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior
McCall, J. G., Siuda, E. R., Bhatti, D. L., Lawson, L. A., McElligott, Z. A., Stuber, G. D., & Bruchas, M. R. (2017) · eLife · doi:10.7554/elife.18247 · Cited by 332
Low Dopamine D2 Receptor Binding Potential in Social Phobia
Schneier, F. R., Liebowitz, M. R., Abi-Dargham, A., Zea-Ponce, Y., Lin, S.-H., & Laruelle, M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.457 · Cited by 325
Albert, P. R., Vahid-Ansari, F., & Luckhart, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00199 · Cited by 321
Stress, depression and the mesolimbic dopamine system
Cabib, S., & Puglisi-Allegra, S. (1996) · Psychopharmacology · doi:10.1007/s002130050142 · Cited by 314
Anorexia nervosa and obesity are associated with opposite brain reward response
Frank, G. K. W., Reynolds, J. R., Shott, M. E., Jappe, L., Yang, T. T., Tregellas, J. R., & O'Reilly, R. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.51 · Cited by 311
Serotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311
Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder
Lanzenberger, R. R., Mitterhauser, M., Spindelegger, C., Wadsak, W., Klein, N., Mien, L.-K., Holik, A., Attarbaschi, T., Mossaheb, N., Sacher, J., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.022 · Cited by 300
Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists
Gray, J. A., & Roth, B. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00623-2 · Cited by 296
Relation of obesity to consummatory and anticipatory food reward
Stice, E., Spoor, S., Ng, J., & Zald, D. H. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.03.020 · Cited by 292
Serotonin, the periaqueductal gray and panic
Graeff, F. G. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.12.004 · Cited by 285
Roy, A. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810070035005 · Cited by 284
Serotonin and anxiety revisited
Kahn, R. S., van Praag, H. M., Wetzler, S., Asnis, G. M., & Barr, G. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90091-1 · Cited by 258
Bhagwagar, Z., Rabiner, E. A., Sargent, P. A., Grasby, P. M., & Cowen, P. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001401 · Cited by 254
Role of norepinephrine in depression.
Delgado, P. L., & Moreno, F. A. (2000) · PubMed · Cited by 251
Bagdy, G., Graf, M., Anheuer, Z. E., Modos, E. A., & Kantor, S. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002632 · Cited by 247
Compositional Lineation and Its Relation to Complex Folding
Newhouse, W. H. (1955) · Science · doi:10.1126/science.122.3163.284-a · Cited by 232
Parsey, R. V., Olvet, D. M., Oquendo, M. A., Huang, Y.-Y., Ogden, R. T., & Mann, J. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300992 · Cited by 227
Compositional Lineation and Its Relation to Complex Folding
Newhouse, W. H. (1955) · Science · doi:10.1126/science.122.3163.284.a · Cited by 226
5-HT and antidepressants: new views from microdialysis studies
Artigas, F. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90125-4 · Cited by 215
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Stahl, S. M. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009053365 · Cited by 210
Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex
Biver, F., Wikler, D., Lotstra, F., Damhaut, P., Goldman, S., & Mendlewicz, J. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.5.444 · Cited by 197
Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides
Boldrini, M., Underwood, M. D., Mann, J. J., & Arango, V. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.004 · Cited by 190
Reader, B. F., Jarrett, B. L., McKim, D. B., Wohleb, E. S., Godbout, J. P., & Sheridan, J. F. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.001 · Cited by 179
Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study
Nash, J. R., Sargent, P. A., Rabiner, E. A., Hood, S. D., Argyropoulos, S. V., Potokar, J. P., Grasby, P. M., & Nutt, D. J. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.041186 · Cited by 177
Serotonin receptors in depression: from A to B
Nautiyal, K. M., & Hen, R. (2017) · F1000Research · doi:10.12688/f1000research.9736.1 · Cited by 173
Boshuisen, M. L., Ter Horst, G. J., Paans, A. M. J., Reinders, A. A. T. S., & den Boer, J. A. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01355-0 · Cited by 167
Serotonin-1A receptor alterations in depression: a meta-analysis of molecular imaging studies
Wang, L., Zhou, C., Zhu, D., Wang, X., Fang, L., Zhong, J., Mao, Q., Sun, L., Gong, X., Xia, J., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1025-0 · Cited by 162
Murrough, J. W., Henry, S. E., Hu, J., Gallezot, J., Planeta‐Wilson, B., Neumaier, J. F., & Neumeister, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1881-0 · Cited by 155
Serum proteomic profiling of major depressive disorder
Bot, M., Chan, M. K., Jansen, R., Lamers, F., Vogelzangs, N., Steiner, J., Leweke, F. M., Rothermundt, M., Cooper, J. D., Bahn, S., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.88 · Cited by 139
Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze
Rodgers, R. J., Cole, J. C., Cobain, M. R., Daly, P., Doran, P. J., Eells, J. R., & Wallis, P. (1992) · Behavioural Pharmacology · doi:10.1097/00008877-199212000-00009 · Cited by 134
BLACK, K. J., Hershey, T. G., Koller, J. M., Videen, T. O., Mintun, M. A., Price, J. L., & Perlmutter, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012260599 · Cited by 133
Escribá, P. V., Ozaita, A., & García-Sevilla, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300459 · Cited by 132
Increased anterior insula activity in anxious individuals is linked to diminished perceived control
Alvarez, R. P., Kirlic, N., Misaki, M., Bodurka, J., Rhudy, J. L., Paulus, M. P., & Drevets, W. C. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.84 · Cited by 113
Alves, S. H. D. S., Pinheiro, G. D. A., Motta, V., Landeira-Fernández, J., & Cruz, A. P. D. M. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200402000-00005 · Cited by 112
Vicario, C. M., Rafal, R. D., Martino, D., & Avenanti, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.008 · Cited by 109
DeVane, C. L., Chiao, E., Franklin, M., & Kruep, E. J. (2005) · PubMed · Cited by 91
Structural Changes in the Brain in Depression and Relationship to Symptom Recurrence
Bremner, J. D. (2002) · CNS Spectrums · doi:10.1017/s1092852900017442 · Cited by 89
The jitteriness syndrome in panic disorder patients treated with antidepressants.
Pohl, R. B., Yeragani, V. K., Balon, R., & Lycaki, H. (1988) · PubMed · Cited by 86
Clinical pharmacology of anxiolytics and antidepressants: A psychopharmacological perspective
Nutt, D., & Glue, P. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90006-5 · Cited by 80
Ferrés‐Coy, A., Santana, N., Castañé, A., Cortés, R., Carmona, M. C., Tóth, M., Montefeltro, A., Artigas, F., & Bortolozzi, A. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2795-9 · Cited by 75
Brain Serotonin1A Receptor Binding in Major Depression Is Related to Psychic and Somatic Anxiety
Sullivan, G. M., Oquendo, M. A., Simpson, N. R., Heertum, R. L. V., Mann, J. J., & Parsey, R. V. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.006 · Cited by 74
Phillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/7014146 · Cited by 74
An overview of the genetics of psychotic mood disorders
Tsuang, M. T., Taylor, L., & Faraone, S. V. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00096-7 · Cited by 73
Yang, Y. K., Yeh, T. L., Yao, W. J., Lee, I. H., Chen, P. S., Chiu, N.-T., & Lu, R. B. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.08.008 · Cited by 69
A Neural Circuitry Linking Insulin Resistance to Depressed Mood
Ryan, J. P., Sheu, L. K., Critchley, H. D., & Gianaros, P. J. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31824d0865 · Cited by 68
Vicente, M. A., & Zangrossi, H. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000873 · Cited by 67
Strigo, I. A., Matthews, S. C., & Simmons, A. N. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.15 · Cited by 61
Li, B., Dong, L., Wang, B., Cai, L., Jiang, N., & Peng, L. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0814-1 · Cited by 58
5-HT1AReceptor-Mediated Autoinhibition and the Control of Serotonergic Cell Firing
Andrade, R., Huereca, D., Lyons, J. G., Andrade, E. M., & McGregor, K. M. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00034 · Cited by 57
The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Quesseveur, G., Gardier, A. M., & Guiard, B. P. (2013) · Current Drug Targets · doi:10.2174/13894501113149990209 · Cited by 55
A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder.
Bystritsky, A., Kerwin, L. E., Feusner, J. D., & Vapnik, T. (2008) · PubMed · Cited by 48
Homan, P., Neumeister, A., Nugent, A. C., Charney, D. S., Drevets, W. C., & Hasler, G. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.25 · Cited by 46
Stahl’s Essential Psychopharmacology
Doyle, B. B. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14bk09672 · Cited by 45
Mischoulon, D., Dougherty, D. D., Bottonari, K. A., Gresham, R. L., Sonawalla, S. B., Fischman, A. J., & D, M. F. M. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00082-3 · Cited by 45
Management of patients with depression associated with anxiety symptoms.
Nutt, D. (1997) · PubMed · Cited by 43
The Antidepressant Effects of 5-HT Uptake Inhibitors
Åberg-Wistedt, A. (1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291745 · Cited by 42
Vilazodone: A novel antidepressant
Choi, E., Zmarlicka, M. T., & Ehret, M. J. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110374 · Cited by 41
Bressa, G. M., Marini, S., & Gregori, S. (1987) · PubMed · Cited by 41
Wenzel, J. M., Cotten, S. W., Dominguez, H. M., Lane, J. E., Shelton, K., Su, Z., & Ettenberg, A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3861-13.2014 · Cited by 39
Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
Kindt, M., Soeter, M., & Sevenster, D. (2014) · Journal of Visualized Experiments · doi:10.3791/52151 · Cited by 37
Castellano, S., Ventimiglia, A., Salomone, S., Ventimiglia, A., Vivo, S., Signorelli, M., Bellelli, E., Santagati, M., Cantarella, R., Fazio, E., et al. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666161003170312 · Cited by 31
Lowther, S., Katona, C., Crompton, M. R., & Horton, R. W. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000259 · Cited by 30
The Relationship Between CSF HVA/5-HIAA Ratio and Suicide Intent in Suicide Attempters
Jokinen, J., Nordström, A., & Nordström, P. (2007) · Archives of Suicide Research · doi:10.1080/13811110701250093 · Cited by 29
Decreased sensitivity of 5-HT1D receptors in melancholic depression
Whale, R., Clifford, E. M., Bhagwagar, Z., & Cowen, P. J. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.5.454 · Cited by 27
Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder
Zhang, X., Norton, J. L., Carrière, I., Ritchie, K. A., Chaudieu, I., Ryan, J. L., & Ancelin, M. (2017) · Scientific Reports · doi:10.1038/srep42676 · Cited by 24
Sumner, J. A., Vrshek‐Schallhorn, S., Mineka, S., Zinbarg, R. E., Craske, M. G., Redei, E. E., Wolitzky-Taylor, K. B., & Adam, E. K. (2013) · Cognition & Emotion · doi:10.1080/02699931.2013.865596 · Cited by 17
Empathic accuracy and oxytocin after tryptophan depletion in adults at risk for depression
Hogenelst, K., Schoevers, R. A., Kema, I. P., Sweep, F. C. G. J., & Rot, M. A. H. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4093-9 · Cited by 16
Vianna, D. M. L., & Carrive, P. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00232.2009 · Cited by 14
Understanding the pharmacogenetics of selective serotonin reuptake inhibitors
Fabbri, C., Minarini, A., Niitsu, T., & Serretti, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.928693 · Cited by 14
Cited by
Kılıç, B., & Aydın, S. (2022) · Neuroinformatics · doi:10.1007/s12021-022-09579-2 · Cited by 112
Detka, J., & Głombik, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00274-8 · Cited by 79
Chan, D. G., Ventura, K., Villeneuve, A., Du Bois, P., & Holahan, M. R. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223461 · Cited by 24
Perić, I., Costina, V., Gass, P., Findeisen, P., & Filipović, D. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.11.013 · Cited by 18
Yuan, X., Chai, J., Xu, W., & Zhao, Y. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10326-z · Cited by 15
Metadata
- Authors
- Liu, Y., Zhao, J., & Guo, W.
- Venue
- Frontiers in Psychology
- Publisher
- Frontiers Media SA
- Published
- 2018-11-21
- Volume
- 9
- Pages
- 2201-2201
- ISSN
- 1664-1078 (ISSN-L)
- OpenAlex
- W2901961340
- Cited by
- 261
- References
- 92
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.